Clean Science and Technology Reports Q2 FY2026 Results with Resilient EBITDA Margins, Proposes Board Changes
Clean Science & Technology reported a 3% year-over-year increase in Q2 FY2026 consolidated revenue to INR 238.00 crore, maintaining EBITDA margins at 38.2%. H1 FY2026 saw 6% revenue growth to INR 488.00 crore with a 38.9% EBITDA margin. The company remains debt-free and has commercialized India's largest HALS facility. The Board has proposed several changes including new Independent Director appointments and executive role transitions, subject to shareholder approval via postal ballot.

*this image is generated using AI for illustrative purposes only.
Clean Science & Technology , a leading specialty chemicals manufacturer, has released its financial results for the second quarter of fiscal year 2026, along with proposing significant board changes.
Financial Highlights
Clean Science & Technology Limited reported consolidated revenue of INR 238.00 crore for Q2 FY2026, representing a 3% year-over-year increase. The company maintained resilient EBITDA margins at 38.2% for the quarter.
For the first half of FY2026 (H1):
| Metric | Value |
|---|---|
| Consolidated Revenue | INR 488.00 crore |
| Year-over-Year Growth | 6% |
| EBITDA Margin | 38.9% |
The performance segment's share in the revenue mix increased to 36% in H1 FY2026, up from 30% in the previous year, driven by higher sales of HALS series products. Raw material costs as a percentage of revenue stood at 37.5% for H1 FY2026.
Operational Highlights
- The company maintains a debt-free balance sheet.
- Clean Science & Technology has commercialized the largest HALS facility in India through its subsidiary Clean Fino Chem Ltd.
- Chemical trials for performance chemical 1 are currently underway.
- Construction for performance chemical 2 remains on track.
Board Resolutions and Proposed Changes
The company's Board has recommended several resolutions for shareholder approval through postal ballot:
- Continuation of Ms. Madhu Dubhashi as Independent Director beyond age 75
- Re-appointment of Mr. Keval Doshi for a second five-year term as Independent Director
- Appointment of two new Independent Directors:
- Mr. Raj Kamal
- Ms. Pallavi Gokhale
- Designation changes for executive directors:
- Mr. Ashok Boob: From Managing Director to Whole Time Director-Executive Vice Chairman
- Mr. Siddhartha Sikchi: From Whole Time Director to Managing Director
Postal Ballot Details
The e-voting period for the postal ballot is scheduled from November 17, 2025 to December 16, 2025.
Market Implications
The financial results and proposed board changes present a comprehensive update for investors and market analysts. The proposed changes in board composition and executive roles indicate a potential strategic shift in the company's leadership structure.
The appointment of new independent directors and the continuation of existing ones beyond typical age limits suggest a focus on maintaining experienced oversight while also bringing in fresh perspectives.
The transition of Mr. Ashok Boob to Executive Vice Chairman and Mr. Siddhartha Sikchi to Managing Director represents a significant change in the top management, which could influence the company's strategic direction going forward.
Investors and stakeholders will likely be watching closely to see how these changes, if approved, may impact Clean Science & Technology's operations and market position in the specialty chemicals sector.
Clean Science & Technology continues to be a significant player in the specialty chemicals market, and these developments remain relevant for those tracking the chemical industry and manufacturing sector in India.
Historical Stock Returns for Clean Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.38% | -0.17% | -12.79% | -35.83% | -28.73% | -42.29% |







































